TRANSANAL ENDOSCOPIC MICROSURGERY FOR RECTAL TUMORS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/hz69cw85Keywords:
Transanal endoscopic microsurgery, Rectal tumorsAbstract
Background: Tumors of the rectal region are common. Originally, transanal endoscopic microsurgery (TEM) was intended as a substitute therapy for these lesions.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2014 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 832 articles, whereas the results of our search on SagePub brought up 75 articles. The results of the search conducted for the last year of 2014 yielded a total 7 articles for PubMed and 9 articles for SagePub. In the end, we compiled a total of 5 papers, 4 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: In summary, TEM has proven to be a dynamic technology and essential platform in treating diseases of different disciplines, despite its initial introduction 38 years ago. We assume that its primal indication of small benign adenomas was comparatively mature yet the application of TEM could be expanded to larger ones, its application in rectal cancer could be more flexible and early-stage cancer should not limit the popularization of TEM in large medical institutions, especially in selected patients after neoadjuvant chemoradiotherapy.
References
Phan K, Kahlaee HR, Kim SH, Toh JWT. Laparoscopic vs. robotic rectal cancer surgery and the effect on conversion rates: a meta-analysis of randomized controlled trials and propensity-score-matched studies. Tech Coloproctol. 2019;23(3):221–30.
Liu X, Li J Bin, Shi G, Guo R, Zhang R. Systematic review of single-incision versus conventional multiport laparoscopic surgery for sigmoid colon and rectal cancer. Vol. 16, World Journal of Surgical Oncology. BioMed Central Ltd.; 2018.
Platt E, Dovell G, Smolarek S. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Tech Coloproctol. 2018;22(11):835–45.
Yamada K, Saiki Y, Takano S, Iwamoto K, Tanaka M. Long-term results of intersphincteric resection for low rectal cancer in Japan. Surg Today. 2019;49(4):275–85.
Heidary B, Phang TP, Raval MJ, Brown CJ. Transanal endoscopic microsurgery: A review. Vol. 57, Canadian Journal of Surgery. Canadian Medical Association; 2014. p. 127–38.
Xue X, Lin G. Transanal endoscopic microsurgery: Exploring its indications and novel applications. A narrative review. Vol. 17, Wideochirurgia I Inne Techniki Maloinwazyjne. Termedia Publishing House Ltd.; 2022. p. 95–103.
Sajid MS, Farag S, Leung P, Sains P, Miles WFA, Baig MK. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis. 2014;16(1):2–14.
Veereman G, Vlayen J, Robays J, Fairon N, Stordeur S, Rolfo C, et al. Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard? Crit Rev Oncol Hematol. 2017;114:43–52.
Serra-Aracil X, Pericay C, Badia-Closa J, Golda T, Biondo S, Hernández P, et al. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study). Annals of Oncology. 2023 Jan 1;34(1):78–90.
Gilbert A, Homer V, Brock K, Korsgen S, Geh I, Hill J, et al. Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. Lancet Healthy Longev. 2022 Dec 1;3(12):e825–38.
Stijns RCH, De Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, Van Meerten E, et al. Long-term
Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal
Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study. JAMA Surg. 2019 Jan 1;154(1):47–54.
Quaresima S, Balla A, Franceschilli L, La Torre M, Iafrate C, Shalaby M, et al. Transanal minimally invasive surgery for rectal lesions. Journal of the Society of Laparoendoscopic Surgeons. 2016 Jul 1;20(3).
Singh J, Stift A, Brus S, Kosma K, Mittlböck M, Riss S. Rectal cancer surgery in older people does not increase postoperative complications - a retrospective analysis. World J Surg Oncol. 2014;12(1).
Saclarides TJ. Transanal Endoscopic Microsurgery. Clin Colon Rectal Surg. 2015 Sep 1;28(3):165–75.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
